Gotowe bibliografie tematyczne / Asthma control

Gotowa bibliografia na temat „Asthma control”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Asthma control”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Asthma control"

1

Sharma, M. P. "Asthma: Control with the Homeopathy". Asian Pacific Journal of Health Sciences 3, nr 3 (lipiec 2016): 126–34. http://dx.doi.org/10.21276/apjhs.2016.3.3.20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Fu, Juan-juan, Vanessa M. McDonald, Gang Wang i Peter G. Gibson. "Asthma control". Current Opinion in Pulmonary Medicine 20, nr 1 (styczeń 2014): 1–7. http://dx.doi.org/10.1097/mcp.0000000000000003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Anthonisen, Nick R. "Asthma “Control”". Canadian Respiratory Journal 11, nr 8 (2004): 529–30. http://dx.doi.org/10.1155/2004/678208.

Pełny tekst źródła
Streszczenie:
In this issue of theCanadian Respiratory Journal, Cowie et al (pages 555-558) make the startling claim that "inhaled corticosteroid therapy does not control asthma". This sounds crazy: if inhaled steroids don't control asthma, what does? It turns out not to be crazy. Cowie et al reported on the effectiveness of asthma control according to Canadian guidelines (1) in several large groups of asthmatics evaluated by cross-sectional, one-point-in-time questionnaires. They found that patients on inhaled steroids were less well-controlled than those who were not on inhaled steroids, and that there was a dose effect, in that the larger the dose of inhaled steroids the worse the control. There is, of course, a simple explanation for this; patients with hard-to-control asthma are likely to be prescribed inhaled steroids, and the harder the disease is to control, the higher the dose. However, these findings are compatible with inhaled steroids having a minor effect on asthma control, something that we do not believe (2). There are excellent data from clinical trials (3) that inhaled steroids work, and in population studies (4), their use is associated with improved survival.
Style APA, Harvard, Vancouver, ISO itp.
4

Connolly, C. K., BrianJ Lipworth, Alison Grove i CatherineM Jackson. "Asthma control". Lancet 344, nr 8924 (wrzesień 1994): 760. http://dx.doi.org/10.1016/s0140-6736(94)92254-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

van Schayck, C. P., C. L. A. van Herwaarden, C. van Weel i J. Morley. "Asthma control". Lancet 344, nr 8916 (lipiec 1994): 194–95. http://dx.doi.org/10.1016/s0140-6736(94)92796-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Taylor, D. R., i M. R. Sears. "Asthma control". Lancet 344, nr 8918 (lipiec 1994): 344. http://dx.doi.org/10.1016/s0140-6736(94)91387-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Vernon, Margaret K., Jill A. Bell, Ingela Wiklund, Peter Dale i Kenneth R. Chapman. "Asthma Control and Asthma Triggers". Journal of Asthma & Allergy Educators 4, nr 4 (27.03.2013): 155–64. http://dx.doi.org/10.1177/2150129713483307.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

COCKCROFT, D., i V. SWYSTUN. "Asthma control versus asthma severity☆☆☆★". Journal of Allergy and Clinical Immunology 98, nr 6 (grudzień 1996): 1016–18. http://dx.doi.org/10.1016/s0091-6749(96)80185-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Cardoso, Mariana Nadal, Herberto José Chong Neto, Lêda Maria Rabelo, Carlos Antônio Riedi i Nelson Augusto Rosário. "Utility of Asthma Control Questionnaire 7 in the assessment of asthma control". Jornal Brasileiro de Pneumologia 40, nr 2 (kwiecień 2014): 171–74. http://dx.doi.org/10.1590/s1806-37132014000200011.

Pełny tekst źródła
Streszczenie:
Our objective was to evaluate the reproducibility of Asthma Control Questionnaire 7 (ACQ-7) in asthma patients, comparing our results against those obtained with the Global Initiative for Asthma (GINA) criteria. We evaluated 52 patients. Patients completed the ACQ-7, underwent spirometry, and were clinically assessed to determine the level of asthma control according to the GINA criteria, in two visits, 15 days apart. The ACQ-7 cutoff for uncontrolled asthma was a score of 1.5. The ACQ-7 showed good reproducibility, with a correlation coefficient of 0.73. The ACQ-7 identified a greater number of patients with uncontrolled asthma than did the GINA criteria; according to the GINA criteria, 47 patients (90.4%) presented with partially controlled asthma.
Style APA, Harvard, Vancouver, ISO itp.
10

Bateman, Eric D. "Measuring asthma control". Current Opinion in Allergy and Clinical Immunology 1, nr 3 (1.06.2001): 211–16. http://dx.doi.org/10.1097/01.all.0000011016.78645.8e.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Asthma control"

1

Thomas, Dr Mike. "Dysfunctional breathing and asthma : can breathing exercises improve asthma control?" Thesis, University of Aberdeen, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.531907.

Pełny tekst źródła
Streszczenie:
The hypothesis underlying this thesis was that abnormal, dysfunctional breathing may occur commonly in people with asthma, and when identified and treated using a breathing training programme supervised by a physiotherapist, will result in improved asthma control.  The thesis is based around four original research papers published in peer-reviewed journals.  These papers present epidemiological surveys quantifying the extent of symptoms attributable to dysfunctional breathing in adults with asthma in comparison with the non-asthmatic adult population, and randomised controlled trials investigating the effectiveness of a breathing training programme in improving asthma control. Initially, a review of the existing evidence of co-morbidity between asthma and dysfunctional breathing is presented, together with that of effectiveness of breathing training interventions.  In subsequent chapters, two epidemiological surveys are presented, showing that symptoms consistent with dysfunctional breathing were more common in the asthmatic than the non-asthmatic adult population.  Data from a pilot and a subsequent full randomised controlled trial are then presented.  These show that breathing training was associated with improved patient-reported outcomes in comparison with a control intervention of asthma education (chosen to control for the non-specific effects of professional contact and interest on a symptomatic patient). The thesis shows that in a clinical trial situation, many people with asthma can benefit from breathing training.
Style APA, Harvard, Vancouver, ISO itp.
2

Sothirajah, Shobana. "Clinical Algorithms for Maintaining Asthma Control". Thesis, The University of Sydney, 2008. http://hdl.handle.net/2123/3546.

Pełny tekst źródła
Streszczenie:
Rationale: Asthma management aims to achieve optimal control on the minimal effective dose of medication. We assessed the effectiveness of two algorithms to guide ICS dose in well-controlled patients on ICS+LABA in a double-blind study, comparing dose adjustment guided by exhaled nitric oxide (eNO) to clinical care algorithm(CCA) based on symptoms and lung function. Methods: We randomised non-smoking adult asthmatics on minimum FP dose 100μgs daily +LABA to ICS adjustment using eNO or CCA, assessed over 5 visits during 8 months treatment. Primary endpoints were asthma-free days and asthma related quality of life (QOL). Analysis was by mixed model regression and generalised estimating equations with log link. Results: 69 subjects were randomised (eNO:34, CCA:35) and 58 completed the study. At baseline mean FEV1 was 94% pred., mean eNO (200ml/sec) 7.1 ppb, median ACQ6 score 0.33. Median ICS dose was 500 μg (IQR 100-500) at baseline and 100 μg on both eNO (IQR 100-200) and CCA arms (IQR 100–100) at end of study. There were no significant differences between eNO and CCA groups in asthma-free days (RR=0.92, 95% CI 0.8–1.01), AQL (RRAQL
Style APA, Harvard, Vancouver, ISO itp.
3

Sothirajah, Shobana. "Clinical Algorithms for Maintaining Asthma Control". University of Sydney, 2008. http://hdl.handle.net/2123/3546.

Pełny tekst źródła
Streszczenie:
Master of Science in Medicine
Rationale: Asthma management aims to achieve optimal control on the minimal effective dose of medication. We assessed the effectiveness of two algorithms to guide ICS dose in well-controlled patients on ICS+LABA in a double-blind study, comparing dose adjustment guided by exhaled nitric oxide (eNO) to clinical care algorithm(CCA) based on symptoms and lung function. Methods: We randomised non-smoking adult asthmatics on minimum FP dose 100μgs daily +LABA to ICS adjustment using eNO or CCA, assessed over 5 visits during 8 months treatment. Primary endpoints were asthma-free days and asthma related quality of life (QOL). Analysis was by mixed model regression and generalised estimating equations with log link. Results: 69 subjects were randomised (eNO:34, CCA:35) and 58 completed the study. At baseline mean FEV1 was 94% pred., mean eNO (200ml/sec) 7.1 ppb, median ACQ6 score 0.33. Median ICS dose was 500 μg (IQR 100-500) at baseline and 100 μg on both eNO (IQR 100-200) and CCA arms (IQR 100–100) at end of study. There were no significant differences between eNO and CCA groups in asthma-free days (RR=0.92, 95% CI 0.8–1.01), AQL (RRAQL
Style APA, Harvard, Vancouver, ISO itp.
4

Goodman, Neil. "Electrostatic allergen control". Thesis, University of Southampton, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249630.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Eilayyan, Owis. "Maximizing the effects of asthma interventions: predictors of perceived asthma control over time". Thesis, McGill University, 2013. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=114582.

Pełny tekst źródła
Streszczenie:
Background: Asthma is a common chronic disease that causes substantial morbidity and reduced quality of life when poorly controlled. Identifying clinical and psychosocial characteristics that influence long-term asthma control can help to match asthma management programs to the individuals' needs. Objective: Study1: To estimate the extent to which symptom status, beliefs about medications, self-efficacy, emotional function, and health care utilization predict perceived asthma control perceived asthma control over a 16 months period of time among a primary care population. Study2: To estimate the extent to which symptom status, physical, mental, and social function, and healthcare utilization predict perceived asthma control over a 6 month period of time among individuals receiving care at a respiratory specialty clinic. Methods: Study 1 and 2 are secondary analysis of data from two longitudinal studies that examined health outcomes of asthma. The first study recruited the participants from primary clinics, while the second one recruited the participants from a specialty clinic at a Montreal territory hospital. Evaluations on measures of symptom status, beliefs about medications, self-efficacy, physical, mental, and social function, and healthcare utilization were evaluated over 2 time points. Path analysis models were used to estimate the predictors of perceived asthma control in both studies, which were modeled based on the Wilson & Cleary and ICF models. The first study's path model hypothesized that symptoms, self-efficacy, beliefs about medications, emotional function, physical activity, and healthcare utilization are predictors of perceived asthma control. The second study's path model hypothesized that FEV1, symptom, mental health, physical and social function, role emotional, and healthcare utilization are predictors of perceived asthma control. Results: Study1: the path model indicated asthma symptom (B= 0.35, p= 0.00) and physical activity (B= 0.24, p= 0.01) had a significant positive total effect on perceived asthma control, while emotional function (B= 0.08, p= 0.05) and self-efficacy (B= 0.07, p= 0.02) were significant predictors indirectly through physical activity. The model explained 24% of perceived asthma control. Overall, the model fit the data well (Χ2 = 15.98, df = 10, P-value = 0.1, RMSEA = 0.045, and CFI = 0.98). Study 2: the path model indicated that FEV (B= 0.12, p= 0.01), asthma symptom (B= 0.42, p= 0.001), and social function (B= 0.37, p= 0.02) had a significant positive total effect on perceived asthma control. The model explained 34% of perceived asthma control. Overall, the model fit the data well (Χ2= 39.83, df = 27, P-value = 0.053, RMSEA = 0.065, and CFI = 0.95). Conclusion: FEV1, asthma symptom, physical activity, emotional function, social function, and self-efficacy can be used to identify patients likely to have poor perceived asthma control in the future, and should be considered when planning patient management. Identifying these predictors is important to help the care team tailor interventions that will allow individuals to optimally manage their asthma, to prevent exacerbations, to prevent other respiratory-related chronic disease, and to maximise quality of life.
Contexte: L'asthme entraîne une morbidité importante et réduit la qualité de vie lorsqu'elle est mal contrôlée. L'identification des caractéristiques cliniques et psychosociales qui influent sur contrôle de l'asthme à long terme peut aider à faire concorder les programmes de gestion de l'asthme aux besoins des individus. Objectif: Étude 1: Estimer la mesure dans laquelle le statut des symptômes, les croyances concernant les médicaments, l'auto-efficacité, l'émotion, et l'utilisation des soins de santé permettent de prédire le contrôle de l'asthme perçu sur une période de 16 mois dans une population des soins primaires. Étude 2: Estimer la mesure dans laquelle le statut des symptômes physiques et mentaux, les fonctions sociales, et l'utilisation des soins de santé permettent de prédire le contrôle de l'asthme perçu sur une période de 6 mois chez les personnes recevant des soins dans une clinique spécialisée en pneumologie.Méthodes: Les études 1 et 2 sont des analyses secondaires des données provenant de deux études longitudinales qui ont examiné les effets de l'asthme sur la santé. La première étude a recruté les participants de cliniques de soins primaires, tandis que la seconde a recruté les participants à partir d'une clinique spécialisée dans un hôpital à Montréal. Les évaluations sur les mesures de l'état de symptôme, les croyances concernant les médicaments, l'auto-efficacité, physique, mental, et les fonctions sociales, et l'utilisation des soins de santé ont été évaluées à 2 points dans le temps. Des modèles d'analyse de pistes causales ont été utilisés pour estimer les facteurs prédictifs de le contrôle de l'asthme perçu dans les deux études. Les modèles utilisés se basent sur les modèles Wilson & Cleary et modèles ICF. Le modèle de piste pour la première étude a émis l'hypothèse que les symptômes, les auto-efficacités, les croyances au sujet des médicaments, l'émotion, l'activité physique, et l'utilisation des soins de santé sont des facteurs prédictifs du contrôle de l'asthme perçu. Le modèle de piste pour la deuxième étude a émis l'hypothèse que le VEMS, les symptômes, la santé mentale, les fonctions physiques et sociales, le rôle émotionnel, et l'utilisation des soins de santé sont des facteurs prédictifs du contrôle de l'asthme perçu. Résultats: Étude 1: le modèle de piste causale a indiqué que les symptômes de l'asthme (B = 0,35, p = 0,00) et l'activité physique (B = 0,24, p = 0,01) ont eu un effet positif important sur la le contrôle de l'asthme perçu totale, tandis que la fonction émotive (B = 0,08, p = 0,05) et l'auto-efficacité (B = 0,07, p = 0,02) étaient des prédicteurs significatifs indirectement au moyen de l'activité physique. Le modèle explique 24% de la le contrôle de l'asthme perçu. Les statistiques d'ajustement indiquent un bon ajustement du modèle (= 15,98 Χ2, df = 10, P-value = 0,1, RMSEA = 0,045, et la FCI = 0,98). Étude 2: le modèle de piste causale a indiqué que le VEMS (B = 0,12, p = 0,01), les symptômes d'asthme (B = 0,42, p = 0,001), et la fonction sociale (B = 0,37, p = 0,02) a eu un effet positif important sur la le contrôle de l'asthme perçu totale. Le modèle explique 34% de la le contrôle de l'asthme perçu. Les statistiques d'ajustement indiquent un bon ajustement du modèle (= 39,83 Χ2, df = 27, P-value = 0,053, RMSEA = 0,065, et la FCI = 0,95). Conclusion: Le VEMS, les symptômes de l'asthme, l'activité physique, la fonction émotive, la fonction sociale, et l'auto-efficacité peuvent être utilisés pour identifier les patients susceptibles d'avoir une mauvaise le contrôle de l'asthme perçu dans l'avenir, et devrait être considéré lors de la planification de gestion des patients. L'identification de ces prédicteurs est une étape importante pour aider les équipes d'interventions à administrer des soins sur mesure afin de contrôler l'asthme et les exacerbations des patients de façon optimale, mais également de prévenir les maladies chroniques associées, et de maximiser la qualité de vie.
Style APA, Harvard, Vancouver, ISO itp.
6

Cameron, Euan John. "Effects of azithromycin on asthma control, airway inflammation and bacterial colonisation in smokers with asthma : a randomised control trial". Thesis, University of Glasgow, 2013. http://theses.gla.ac.uk/4575/.

Pełny tekst źródła
Streszczenie:
Smokers with asthma represent an important sub-group of asthmatics displaying both reduced response to inhaled and oral corticosteroids as well as demonstrating accelerated decline in lung function and increased use of health care services. Clinical and laboratory studies have suggested that macrolide antibiotics may exhibit anti-inflammatory properties in a variety of airways disease including asthma. The anti-inflammatory properties of macrolides have been recognised for almost 50 years. Indirect evidence from both pre-clinical and clinical studies suggests that the mechanism of action may be of particular benefit in smokers with asthma. A proof of concept study was designed to test the hypothesis that the macrolide antibiotic azithromycin improves measures of asthma control, airway inflammation and bacterial colonisation in smokers with asthma. Azithromycin was chosen for its convenience of once daily dosing and its oral tolerability in addition to its more limited interactions. Seventy-seven adults with allergic asthma were recruited to a 12-week parallel group randomised controlled trial comparing the effects on asthma control, airway inflammation and bacterial colonisation of oral azithromycin 250 mg daily with matched placebo. The primary outcome measure was peak expiratory flow at the final study visit. Secondary outcome measures included spirometry, asthma control questionnaire [ACQ] score, asthma quality of life questionnaire [AQLQ], Leicester cough questionnaire [LCQ] score, provocation concentration to methacholine PC20, and inflammatory markers: exhaled nitric oxide, sputum differential cell counts, sputum supernatant and serum inflammatory markers such as interleukin-1β [IL-1β], IL-2, -4, -5, -6, -10, TNF-α, IFN-γ, GM-CSF, Leukotriene B4, and high sensitivity C-reactive protein. Microbiological culture and PCR of sputum was also performed to assess for any changes associated with treatment. At 12 weeks, the change in PEF at the final study visit, as compared with baseline, did not differ significantly between the azithromycin and placebo treatment groups [mean difference azithromycin-placebo -10.3L/min, 95% CI -47.1 to 26.4, p=0.58]. No statistically significant difference was observed between the azithromycin and placebo groups in each of the measures of spirometry, ACQ, AQLQ, LCQ, PC20, or evening PEF. The LCQ-psychological domain did reach statistical significance, [mean difference azithromycin-placebo -0.46, 95%CI -0.9 to 0.02 p=0.04], however this indicates a deterioration in the treatment group. No change was seen in exhaled nitric oxide. The total cell counts recovered from sputum were similar following treatment with azithromycin compared to placebo. In addition, differential cell counts remained unchanged and lymphocyte proliferation assays did not demonstrate any statistically significant changes following 12 weeks of treatment with azithromycin when compared to placebo. There was no substantial difference in any of the measured sputum supernatant or plasma cytokines. Peripheral blood monocyte stimulation was performed, with supernatant being measured against a panel of cytokines. There was again no substantial difference in any of the measured panel of cytokines collected from the monocyte stimulation assays when the azithromycin group was compared to placebo. There was no correlation between changes in ACQ, AQLQ, LCQ, PC20, sputum macrophage count, sputum neutrophil count, sputum eosinophil count, and PEF. Adverse event rates were similar in patients taking azithromycin compared with placebo. A total of 4 patients were lost to follow up [1 in the azithromycin group, 3 in the placebo group]. One patient died of a cardiovascular cause. This occurred following completion of the study but within the pre-specified regulatory reporting period. In conclusion there were no clinically important improvements in a range of clinical indices of asthma control, airway inflammation or bacterial colonisation following 12 weeks treatment with azithromycin when compared with placebo in smokers with asthma. The lack of any evidence of clinical benefit of azithromycin in smokers with asthma is a new finding and extends the current knowledge base and evidence for the use of macrolides in asthma. There exists no firm evidence to suggest the widespread use of macrolides in asthma and the current study suggests that no benefit will be observed in the sub-group of asthmatics whom are current smokers.
Style APA, Harvard, Vancouver, ISO itp.
7

Smith, Nerida Ann. "The effects of intervention on medication compliance and asthma control in children with asthma". Thesis, The University of Sydney, 1987. http://hdl.handle.net/2123/1613.

Pełny tekst źródła
Streszczenie:
Asthma can be a chronic disorder requiring regular medications if the symptoms are persistent. The regimen is often complex, involving a number of drugs and a variety or routes of administration. Although drug therapy may not alter the natural history of asthma it can improve lung function enabling those with asthma to lead as near a normal life as possible. Thus medication compliance is an important factor in the managemnt of asthma. (Note : Special enclosures (Publication reprints) at end of thesis have been removed for digital submission, with permission of author)
Style APA, Harvard, Vancouver, ISO itp.
8

Smith, Nerida Ann. "The effects of intervention on medication compliance and asthma control in children with asthma". University of Sydney, 1987. http://hdl.handle.net/2123/1613.

Pełny tekst źródła
Streszczenie:
Doctor of Philosophy
Asthma can be a chronic disorder requiring regular medications if the symptoms are persistent. The regimen is often complex, involving a number of drugs and a variety or routes of administration. Although drug therapy may not alter the natural history of asthma it can improve lung function enabling those with asthma to lead as near a normal life as possible. Thus medication compliance is an important factor in the managemnt of asthma. (Note : Special enclosures (Publication reprints) at end of thesis have been removed for digital submission, with permission of author)
Style APA, Harvard, Vancouver, ISO itp.
9

Neffen, Hugo, Carlos Fritscher, Francisco Cuevas Schacht, Gur Levy, Pascual Chiarella, Joan B. Soriano i Daniel Mechali. "Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey". Pan American Health Organization, 2005. http://hdl.handle.net/10757/625754.

Pełny tekst źródła
Streszczenie:
Objectives. The aims of this survey were (1) to assess the quality of asthma treatment and control in Latin America, (2) to determine how closely asthma management guidelines are being followed, and (3) to assess perception, knowledge and attitudes related to asthma in Latin America. Methods. We surveyed a household sample of 2 184 adults or parents of children with asthma in 2003 in 11 countries in Latin America. Respondents were asked about healthcare utilization, symptom severity, activity limitations and medication use. Results. Daytime asthma symptoms were reported by 56% of the respondents, and 51 % reported being awakened by their asthma at night. More than half of those surveyed had been hospitalized, attended a hospital emergency service or made unscheduled emergency visits to other healthcare facilities for asthma during the previous year. Patient perception of asthma control did not match symptom severity, even in patients with severe persistent asthma, 44.7% of whom regarded their disease as being well or completely controlled. Only 2.4% (2.3% adults and 2.6% children) met all criteria for asthma control. Although 37% reported treatment with prescription medications, only 6% were using inhaled corticosteroids. Most adults (79%) and children (68%) in this survey reported that asthma symptoms limited their activities. Absence from school and work was reported by 58% of the children and 31% of adults, respectively. Conclusions. Asthma control in Latin America falls short of goals in international guidelines, and in many aspects asthma care and control in Latin America suffer from the same shortcomings as in other areas of the world.
Revisión por pares
Style APA, Harvard, Vancouver, ISO itp.
10

Ställberg, Björn. "Asthma in Primary Care : Severity, Treatment and Level of Control". Doctoral thesis, Uppsala universitet, Allmänmedicin och klinisk epidemiologi, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-9332.

Pełny tekst źródła
Streszczenie:
Aims. The overall aim was to examine the severity, treatment and level of control in patients with asthma in primary care in Sweden. The specific aims were to assess what matters to asthma patients, evaluate symptoms, medication and identify factors related to asthma severity, compare the extent of asthma control in 2001 and 2005, and investigate the development of asthma and degree of asthma control in adolescents and young adults who had reported asthma six years earlier. Methods. The first study was a telephone interview of a representative sample of Swedish asthmatics. In the second study a random sample of 1,136 patients answered two questionnaires. A classification of the asthma severity similar to that in the GINA guidelines was made. In the third study two surveys were performed, in 2001 and in 2005, with a random sample of 1,012 and 224 asthma patients, respectively, and a classification of asthma control similar to the recent GINA guidelines was made. In the fourth study 71 individuals who reported physician-diagnosed asthma in a population-based survey in 1997 and were defined as current asthmatics, were reinvestigated in 2003 with a skin prick test, methacholine challenge test, eucapnic voluntary hyperventilation test and measurement of exhaled nitric oxide. Results. Common situations causing symptoms of asthma were physical exertion and contact with pets. Nocturnal symptoms were frequent. In primary care 35% of the women and 24% of the men were classified as having severe asthma. Female sex, increasing age, not filling the asthma prescription owing to cost, daily smoking, and pollen allergy increased the odds of having severe asthma. In 2001, 37% had achieved asthma control, as compared with 40% in 2005. Uncontrolled asthma was more common in women and smokers. In the 2003 study of adolescents and young adults with asthma six years earlier, the definition of current asthma was fulfilled by 50 of the 71 subjects and one third had achieved asthma control. Conclusions. The majority of the asthmatics reported a large number of symptoms and limitations in their daily living. Many asthma patients in primary care have insufficient asthma control. One reason for lack of control might be undertreatment with inhaled corticosteroids.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Asthma control"

1

1954-, Boulet Louis-Philippe, red. Understand and control your asthma. Montréal: McGill-Queen's University Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Cichorski, Michael E. Maximum asthma control: the revolutionary 3-step anti-asthma program. Melbourne: Michelle Anderson, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Pfuetze, Bruce L. Childhood asthma: A matter of control. [United States?]: American Lung Association, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Harrington, Geri. The asthma self-care book: How to take control of your asthma. New York, NY: HarperPaperbacks, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Harrington, Geri. The asthma self-care book: How to take control of your asthma. New York, NY: HarperCollinsPublishers, 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

McKeown, Patrick. Asthma-free naturally: Everything you need to know to take control of your asthma. San Francisco, Calif: Conari, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

1929-, Nadel Jay A., Pauwels Romain i Snashall P. D, red. Bronchial hyperresponsiveness: Normal and abnormal control, assessment, and therapy. Oxford: Blackwell Scientific Publications, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

B, Weiss Kevin, i Institute for Healthcare Improvement, red. Improving asthma care in children and adults. Boston, MA: Institute for Healthcare Improvement, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Mendoza, Guillermo. Asthma in the school: Improving control with peak flow monitoring. [Cedar Grove, N.J.]: Health Scan, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Rubin, Bruce K. Conquering childhood asthma: An illustrated guide to understanding the treatment and control of childhood asthma. Hamilton, Ont: Empowering Press, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Asthma control"

1

Barnes, Peter J. "Neural Control of Airways". W Asthma Treatment, 9–19. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Persson, Carl G. A. "Plasma Exudation in Asthma and Its Pharmacological Control". W Asthma Treatment, 105–16. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Chetambath, Ravindran. "Difficult-to-Control Asthma". W Clinical Allergy and Asthma Management in Adolescents and Young Adults, 148–53. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9781003125785-20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kazaks, Alexandra. "Magnesium Links to Asthma Control". W Magnesium in Human Health and Disease, 67–80. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-044-1_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Iyengar, Shuba Rajashri. "Prevention and Control Measures in Management of Allergic Diseases". W Allergy and Asthma, 559–68. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-30835-7_36.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Cosme-Blanco, Wilfredo, Yanira Arce-Ayala, Iona Malinow i Sylvette Nazario. "Primary and Secondary Environmental Control Measures for Allergic Diseases". W Allergy and Asthma, 1–36. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-58726-4_36-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Cosme-Blanco, Wilfredo, Yanira Arce-Ayala, Iona Malinow i Sylvette Nazario. "Primary and Secondary Environmental Control Measures for Allergic Diseases". W Allergy and Asthma, 785–819. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-05147-1_36.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Kraemer, R., K. Modelska, C. Casaulta Aebischer i M. H. Schöni. "Comparison of Different Inhalation Schedules to Control Childhood Asthma". W Update on Childhood Asthma, 211–21. Basel: Birkhäuser Basel, 1993. http://dx.doi.org/10.1007/978-3-0348-7385-7_17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Pretolani, M., J. Lefort i B. B. Vargaftig. "Experimental Lung Hyperreactivity: Pharmacological Control and Possible Role of Cytokines". W New Concepts in Asthma, 65–71. London: Macmillan Education UK, 1993. http://dx.doi.org/10.1007/978-1-349-12673-6_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Widdicombe, John. "Pathophysiology of Bronchial Asthma". W Control of the Cardiovascular and Respiratory Systems in Health and Disease, 27–36. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1895-2_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Asthma control"

1

Aruj, P., I. Boyeras, E. Franchi, MA Gimenez, F. Logrado, A. Yanez, G. Apelbaum i RJ Gene. "Asthma Control: FEV1 or ACT (Asthma Control Test)?." W American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1036.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Uematsu, Manabu, Junpei Saito, Suguru Sato, Atsuro Fukuhara, Yasuhito Suzuki, Ryuichi Togawa, Yuki Sato i in. "Association of Asthma Control Test (ACT) and Asthma Control Questionnaire (ACQ) with asthma exacerbation". W ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4436.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Lin, Jiang Tao, Wenqiao Wang, Xin Zhou, Changzhen Wang, Mao Huang, Shaoxi Cai, Ping Chen i in. "Evaluation of asthma control from China national asthma control surveys". W ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa1125.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Nelsen, L., M. Kosinski, A. Rizio, L. Jacques, M. Schatz, R. H. Stanford i H. Svedsater. "A Perspective on Asthma Control Through the Asthma Control Test (ACT)". W American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1335.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Vernon, Margaret K., Ingela Wiklund, Jill Bell, Nancy K. Leidy, Peter Dale i Kenneth R. Chapman. "Asthma Control And Asthma Triggers: The Patient Perspective". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4764.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Azambuja, Renato, Rogério Bartholo, Claudia Costa, Paulo Chauvet, Bruna Marques, Rogerio Rufino, Thiago Mafort i Thiago P. Bartholo. "Obesity And Asthma Control". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1771.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Honkoop, PJ, JB Snoeck-Stroband, MJ Bakker, KF Rabe, V. van der Meer i JK Sont. "Optimal Monitoring Frequency of Asthma Control by the Asthma Control Questionnaire (ACQ)." W American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4068.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Deschildre, Antoine, Kamal El Abd, Jacques de BLIC i Julia Salleron. "Asthma Control Evaluation With Childhood Asthma Control Test In Ambulatory Paediatric Practice". W American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6661.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

GRZETIC- ROMCEVIC, TANJA, SILVANA SONC i BORIS DEVCIC. "Asthma Control Among Tobacco Smoking Adults With Bronchial Asthma". W American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2555.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Sapra, SJ, M. Margolis, A. Rentz i D. Revicki. "Psychometric Evaluation of the Asthma Control Test and Asthma Control Questionnaire in Patients with Moderate to Severe Asthma." W American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4066.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Asthma control"

1

Joudaki, Hossein. Does mobile phone messaging improve self- management of long-term illnesses? SUPPORT, 2017. http://dx.doi.org/10.30846/170412.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Elder, John P., Leticia Ibarra, Deanna Rossi, José Luis Olmedo, Nadia Campbell, Esther Bejarano, Chii-Dean Lin i Guadalupe X. Ayala. Comparing Programs to Improve Asthma Control and Quality of Life for Latino Youth Living in Rural Areas and Their Caregivers -- The Respira Sano Study. Patient-Centered Outcomes Research Institute (PCORI), kwiecień 2021. http://dx.doi.org/10.25302/04.2021.as.130805876.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Codd, Heather, Leslie Fierro, Ann Marie Castleman, Robin Kuwahara, Maureen Wilce, Sarah Gill, Ayana Perkins i in. Planting the Seeds for High-Quality Program Evaluation in Public Health. National Center for Environmental Health ( U.S.), sierpień 2021. http://dx.doi.org/10.15620/cdc:110639.

Pełny tekst źródła
Streszczenie:
Evaluation and evidence-informed decision making are central to public health practice. In recent decades, the professional discipline of evaluation has experienced tremendous growth that can be leveraged for use in public health. To meet the growing need for program evaluation training, the National Asthma Control Program presents the e-textbook Planting the Seeds for High-Quality Program Evaluation in Public Health. This free e-textbook is designed to help public health students and professionals understand evaluation approaches and techniques to improve public health programs.
Style APA, Harvard, Vancouver, ISO itp.
4

Gindi, Renee. Health, United States, 2019. Centers for Disease Control and Prevention (U.S.), 2021. http://dx.doi.org/10.15620/cdc:100685.

Pełny tekst źródła
Streszczenie:
Health, United States, 2019 is the 43rd report on the health status of the nation and is submitted by the Secretary of the Department of Health and Human Services to the President and the Congress of the United States in compliance with Section 308 of the Public Health Service Act. This report was compiled by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). The Health, United States series presents an annual overview of national trends in key health indicators. The 2019 report presents trends and current information on selected measures of morbidity, mortality, health care utilization and access, health risk factors, prevention, health insurance, and personal health care expenditures in a 20-figure chartbook. The Health, United States, 2019 Chartbook is supplemented by several other products including Trend Tables, an At-a-Glance table, and Appendixes available for download on the Health, United States website at: https://www.cdc.gov/nchs/hus/ index.htm. The Health, United States, 2019 Chartbook contains 20 figures and 20 tables on health and health care in the United States. Examining trends in health informs the development, implementation, and evaluation of health policies and programs. The first section (Figures 1–13) focuses on health status and determinants: life expectancy, infant mortality, selected causes of death, overdose deaths, suicide, maternal mortality, teen births, preterm births, use of tobacco products, asthma, hypertension, heart disease and cancer, and functional limitations. The second section (Figures 14–15) presents trends in health care utilization: use of mammography and colorectal tests and unmet medical needs. The third section (Figures 16–17) focuses on health care resources: availability of physicians and dentists. The fourth section (Figures 18–20) describes trends in personal health care expenditures, health insurance coverage, and supplemental insurance coverage among Medicare beneficiaries. The Highlights section summarizes major findings from the Chartbook. Suggested citation: National Center for Health Statistics. Health, United States, 2019. Hyattsville, MD. 2021.
Style APA, Harvard, Vancouver, ISO itp.
5

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel i Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), marzec 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Pełny tekst źródła
Streszczenie:
Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Key Informants. We searched MEDLINE and EMBASE (via EMBASE.com), In-Process MEDLINE and PubMed unique content (via PubMed.gov), and the Cochrane Database of Systematic Reviews for systematic reviews or controlled trials. We also searched ClinicalTrials.gov for ongoing studies. We assessed risk of bias and extracted data on health outcomes, surrogate outcomes, usability, sustainability, cost-effectiveness outcomes (quantifying the tradeoffs between health effects and cost), process outcomes, and other characteristics related to PGHD technologies. For isolated effects on health outcomes, we classified the results in one of four categories: (1) likely no effect, (2) unclear, (3) possible positive effect, or (4) likely positive effect. When we categorized the data as “unclear” based solely on health outcomes, we then examined and classified surrogate outcomes for that particular clinical condition. Findings. We identified 114 unique studies that met inclusion criteria. The largest number of studies addressed patients with hypertension (51 studies) and obesity (43 studies). Eighty-four trials used a single PGHD device, 23 used 2 PGHD devices, and the other 7 used 3 or more PGHD devices. Pedometers, blood pressure (BP) monitors, and scales were commonly used in the same studies. Overall, we found a “possible positive effect” of PGHD interventions on health outcomes for coronary artery disease, heart failure, and asthma. For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight) as likely no effect. For hypertension, we rated the health outcomes as unclear, and the surrogate outcomes (systolic BP/diastolic BP) as possible positive effect. For cardiac arrhythmias or conduction abnormalities we rated the health outcomes as unclear and the surrogate outcome (time to arrhythmia detection) as likely positive effect. The findings were “unclear” regarding PGHD interventions for diabetes prevention, sleep apnea, stroke, Parkinson’s disease, and chronic obstructive pulmonary disease. Most studies did not report harms related to PGHD interventions; the relatively few harms reported were minor and transient, with event rates usually comparable to harms in the control groups. Few studies reported cost-effectiveness analyses, and only for PGHD interventions for hypertension, coronary artery disease, and chronic obstructive pulmonary disease; the findings were variable across different chronic conditions and devices. Patient adherence to PGHD interventions was highly variable across studies, but patient acceptance/satisfaction and usability was generally fair to good. However, device engineers independently evaluated consumer wearable and handheld BP monitors and considered the user experience to be poor, while their assessment of smartphone-based electrocardiogram monitors found the user experience to be good. Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed and relatively easy to use. Implications. Multiple randomized controlled trials (RCTs) have evaluated some PGHD technologies (e.g., pedometers, scales, BP monitors), particularly for obesity and hypertension, but health outcomes were generally underreported. We found evidence suggesting a possible positive effect of PGHD interventions on health outcomes for four chronic conditions. Lack of reporting of health outcomes and insufficient statistical power to assess these outcomes were the main reasons for “unclear” ratings. The majority of studies on PGHD technologies still focus on non-health-related outcomes. Future RCTs should focus on measurement of health outcomes. Furthermore, future RCTs should be designed to isolate the effect of the PGHD intervention from other components in a multicomponent intervention.
Style APA, Harvard, Vancouver, ISO itp.
6

Working in partnership with a British South Asian community could improve control of children’s asthma. National Institute for Health Research, wrzesień 2021. http://dx.doi.org/10.3310/alert_47470.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Asthma control” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii